Video-Intervention to Inspire Treatment Adherence for Life for Adolescents
NCT ID: NCT07064785
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1800 participants
INTERVENTIONAL
2025-07-25
2027-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VITAL Start: Brief Facility-based Video Intervention
NCT03654898
Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial
NCT03149757
Assessment of Group Peer Support to Children With HIV in Vietnam
NCT02035969
Adherence Interventions for HIV Youth Via Text & Cell Phone - Sequential Multiple Assignment Randomized Trial (SMART)
NCT03535337
Improving Antiretroviral Medication Adherence Among HIV-infected Youth
NCT01347437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One of the first video-based interventions integrated into HIV care in Malawi was piloted with preliminary findings showing high satisfaction among patients and providers, as well as improvements in ART knowledge, adherence, and retention. Building on these results, the investigators propose to adapt and evaluate VITAL Start (Video-intervention to Inspire Treatment Adherence for Life) for Adolescents (VS4A), a video-based counseling package tailored for ALHIV.
Through a two-arm randomized controlled trial, the aim is to assess the impact of VS4A on implementation and clinical outcomes. Adolescent-treatment supporters from up to 26 health facilities in Malawi will be randomized to receive either the VS4 intervention or the standard of care (SOC). Implementation outcomes will be compared between the VS4A arm and the standard of care arm. The effectiveness outcome of adolescent viral suppression will be compared between the two arms.
The findings from this trial will provide an intervention that standardizes and improves knowledge and behavior at critical teaching moments through an engaging and culturally sensitive experience and inform scalable strategies to improve adolescent HIV care and advance progress toward long-term viral suppression and well-being for ALHIV.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Video-Based ART Adherence Counseling
Video-based ART adherence counseling
* Clinical visit which includes ART provision at 0, 12 and 24 weeks
* Two one-hour video-based sessions with associated activities at 0 and 12 weeks
* Enhanced/Intensive adherence counselling with video component between 24-35 weeks for those with high viral load
Standard of Care
Standard of Care (SOC)
* Clinical visit which includes ART provision at 0, 12 and 24 weeks
* Basic adherence counselling between 24-35 weeks for those with high viral load
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Video-based ART adherence counseling
* Clinical visit which includes ART provision at 0, 12 and 24 weeks
* Two one-hour video-based sessions with associated activities at 0 and 12 weeks
* Enhanced/Intensive adherence counselling with video component between 24-35 weeks for those with high viral load
Standard of Care (SOC)
* Clinical visit which includes ART provision at 0, 12 and 24 weeks
* Basic adherence counselling between 24-35 weeks for those with high viral load
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In care at the health facility
* Aware of their HIV status
* Provide informed consent (if aged 18+ years) or assent and guardian informed consent (if aged 10-17 years).
* \>18 years old
* named as a treatment supporter of an adolescent study participant
* willing to provide informed consent for oneself
Exclusion Criteria
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina, Chapel Hill
OTHER
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
Baylor College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Saeed Ahmed
Associate Professor of Pediatrics, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saeed Ahmed, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Baylor College of Medicine, Houston Texas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Balaka District Hospital
Balaka, , Malawi
Balaka OPD Health Centre
Balaka, , Malawi
Chiendausiku Health Centre
Balaka, , Malawi
Kalembo Health Centre
Balaka, , Malawi
Kwitanda Health Centre
Balaka, , Malawi
Mbera health Centre
Balaka, , Malawi
Namanolo Health Centre
Balaka, , Malawi
Nandumbo Health Centre
Balaka, , Malawi
Phalula Health Centre
Balaka, , Malawi
Phimbi Health Centre
Balaka, , Malawi
Ulongwe Health Centre
Balaka, , Malawi
Utale 2 Health Centre
Balaka, , Malawi
Chamba Health Centre
Machinga, , Malawi
Chikweo Health Centre
Machinga, , Malawi
Gawanani Health Centre
Machinga, , Malawi
Kawinga Dispensary
Machinga, , Malawi
Machinga Disctrict Hospital
Machinga, , Malawi
Machinga Health Centre
Machinga, , Malawi
Mangamba Health Centre
Machinga, , Malawi
Mbonechela Dispensary
Machinga, , Malawi
Mkwepere Health Centre
Machinga, , Malawi
Mpiri Health Centre
Machinga, , Malawi
Mposa Health Centre
Machinga, , Malawi
Namandanje Health Centre
Machinga, , Malawi
Namanja Health Centre
Machinga, , Malawi
Nayinunje Health Centre
Machinga, , Malawi
Nayuchi Health Centre
Machinga, , Malawi
Ngokwe Health Centre
Machinga, , Malawi
Nsanama Health Centre
Machinga, , Malawi
Ntaja Health Centre
Machinga, , Malawi
Nthorowa Health Centre
Machinga, , Malawi
Nyambi Health Centre
Machinga, , Malawi
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-53963
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.